-
1
-
-
0031814283
-
Update on the role of epoetin alfa in hematologic malignancies and myelodysplastic syndromes
-
Casadevall N. Update on the role of epoetin alfa in hematologic malignancies and myelodysplastic syndromes. Semin Oncol. 1998;25(3 Suppl 7):12-18.
-
(1998)
Semin Oncol
, vol.25
, Issue.3 SUPPL. 7
, pp. 12-18
-
-
Casadevall, N.1
-
2
-
-
0033989427
-
Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
-
Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer. 2000;82:93-97.
-
(2000)
Br J Cancer
, vol.82
, pp. 93-97
-
-
Barrett-Lee, P.J.1
Bailey, N.P.2
O'Brien, M.E.3
Wager, E.4
-
3
-
-
0034533078
-
The impact and management of anaemia in haematological malignancies
-
Coiffier B. The impact and management of anaemia in haematological malignancies. Med Oncol. 2000;17(Suppl 1):S2-S10.
-
(2000)
Med Oncol
, vol.17
, Issue.SUPPL. 1
-
-
Coiffier, B.1
-
4
-
-
0038414196
-
European Cancer Anaemia Survey (EGAS): Prospective evaluation of anemia in over 15,000 cancer (CA) patients (pts)
-
Ludwig H, Birgegård G, Olmi P, Nortier J. European Cancer Anaemia Survey (EGAS): prospective evaluation of anemia in over 15,000 cancer (CA) patients (pts) [abstract]. Ann Oncol. 2002;13(Suppl 5);169.
-
(2002)
Ann Oncol
, vol.13
, Issue.SUPPL. 5
, pp. 169
-
-
Ludwig, H.1
Birgegård, G.2
Olmi, P.3
Nortier, J.4
-
5
-
-
0031842412
-
Factors influencing quality of life in cancer patients: Anemia and fatigue
-
Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Semin Oncol. 1998;25(3 Suppl 7):43-46.
-
(1998)
Semin Oncol
, vol.25
, Issue.3 SUPPL. 7
, pp. 43-46
-
-
Cella, D.1
-
6
-
-
0035400246
-
Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
-
Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys. 2001;50:705-715.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.50
, pp. 705-715
-
-
Glaser, C.M.1
Millesi, W.2
Kornek, G.V.3
-
7
-
-
0035367087
-
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial
-
Epoetin Alfa Study Group
-
Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. Epoetin Alfa Study Group. J Clin Oncol. 2001;19:2865-2874.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2865-2874
-
-
Littlewood, T.J.1
Bajetta, E.2
Nortier, J.W.3
Vercammen, E.4
Rapoport, B.5
-
8
-
-
0034993236
-
Symptomatology of anemia
-
Ludwig H, Strasser K. Symptomatology of anemia. Semin Oncol. 2001;28(2 Suppl 8):7-14.
-
(2001)
Semin Oncol
, vol.28
, Issue.2 SUPPL. 8
, pp. 7-14
-
-
Ludwig, H.1
Strasser, K.2
-
9
-
-
0028068659
-
Symptom problems, characteristics, and distress in a cancer population
-
Portenoy RK, Thaler HT, Kornblith AB, et al. Symptom problems, characteristics, and distress in a cancer population. Qual Life Res. 1994;3:183-189.
-
(1994)
Qual Life Res
, vol.3
, pp. 183-189
-
-
Portenoy, R.K.1
Thaler, H.T.2
Kornblith, A.B.3
-
10
-
-
0030877720
-
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey
-
The Fatigue Coalition
-
Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997;34(3 Suppl 2):4-12.
-
(1997)
Semin Hematol
, vol.34
, Issue.3 SUPPL. 2
, pp. 4-12
-
-
Vogelzang, N.J.1
Breitbart, W.2
Cella, D.3
-
13
-
-
0034097944
-
The impact of fatigue on patients with cancer: Overview of FATIGUE 1 and 2
-
Curt GA. The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist. 2000;5(Suppl 2):9-12.
-
(2000)
Oncologist
, vol.5
, Issue.SUPPL. 2
, pp. 9-12
-
-
Curt, G.A.1
-
14
-
-
0033807848
-
Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey
-
Cancer Fatigue Forum
-
Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol. 2000;11:971-975.
-
(2000)
Ann Oncol
, vol.11
, pp. 971-975
-
-
Stone, P.1
Richardson, A.2
Ream, E.3
Smith, A.G.4
Kerr, D.J.5
Kearney, N.6
-
15
-
-
0041464817
-
Assessment and management of cancer-related fatigue in adults
-
Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640-650.
-
(2003)
Lancet
, vol.362
, pp. 640-650
-
-
Ahlberg, K.1
Ekman, T.2
Gaston-Johansson, F.3
Mock, V.4
-
16
-
-
0141603243
-
Fatigue and the cancer experience: The state of the knowledge
-
Winningham ML, Nail LM, Burke MB, et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994;21:23-36.
-
(1994)
Oncol Nurs Forum
, vol.21
, pp. 23-36
-
-
Winningham, M.L.1
Nail, L.M.2
Burke, M.B.3
-
17
-
-
0031843031
-
Anemia in cancer patients
-
Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol. 1998;25(3 Suppl 7):2-6.
-
(1998)
Semin Oncol
, vol.25
, Issue.3 SUPPL. 7
, pp. 2-6
-
-
Ludwig, H.1
Fritz, E.2
-
18
-
-
0032063729
-
The Schwartz Cancer Fatigue Scale: Testing and reliability
-
Schwartz AL. The Schwartz Cancer Fatigue Scale: testing and reliability. Oncol Nurs Forum. 1998;25:711-717.
-
(1998)
Oncol Nurs Forum
, vol.25
, pp. 711-717
-
-
Schwartz, A.L.1
-
19
-
-
0141770313
-
Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus
-
Krantz SB, Goldwasser E. Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus. Proc Natl Acad Sci USA. 1984;81:7574-7578.
-
(1984)
Proc Natl Acad Sci USA
, vol.81
, pp. 7574-7578
-
-
Krantz, S.B.1
Goldwasser, E.2
-
20
-
-
0022484262
-
Characterization and biological effects of recombinant human erythropoietin
-
Egrie JC, Strickland TW, Lane J, et al. Characterization and biological effects of recombinant human erythropoietin. Immunobiology. 1986;172:213-224.
-
(1986)
Immunobiology
, vol.172
, pp. 213-224
-
-
Egrie, J.C.1
Strickland, T.W.2
Lane, J.3
-
21
-
-
0023664340
-
Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells
-
Sawyer ST, Krantz SB, Goldwasser E. Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem. 1987;262:5554-5562.
-
(1987)
J Biol Chem
, vol.262
, pp. 5554-5562
-
-
Sawyer, S.T.1
Krantz, S.B.2
Goldwasser, E.3
-
22
-
-
0025314238
-
Erythropoietin treatment of anemia associated with multiple myeloma
-
Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med. 1990;322:1693-1699.
-
(1990)
N Engl J Med
, vol.322
, pp. 1693-1699
-
-
Ludwig, H.1
Fritz, E.2
Kotzmann, H.3
Hocker, P.4
Gisslinger, H.5
Barnas, U.6
-
23
-
-
0025732160
-
Erythropoietin is both a mitogen and a survival factor
-
Spivak JL, Pham T, Isaacs M, Hankins WD. Erythropoietin is both a mitogen and a survival factor. Blood. 1991;77:1228-1233.
-
(1991)
Blood
, vol.77
, pp. 1228-1233
-
-
Spivak, J.L.1
Pham, T.2
Isaacs, M.3
Hankins, W.D.4
-
24
-
-
0026535007
-
Recombinant human erythropoietin in the treatment of the anaemia of cancer
-
Abels RI. Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematol. 1992;87(Suppl 1):4-11.
-
(1992)
Acta Haematol
, vol.87
, Issue.SUPPL. 1
, pp. 4-11
-
-
Abels, R.I.1
-
25
-
-
0026736065
-
Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer
-
Abels RI. Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol. 1992;19(3 Suppl 8):29-35.
-
(1992)
Semin Oncol
, vol.19
, Issue.3 SUPPL. 8
, pp. 29-35
-
-
Abels, R.I.1
-
26
-
-
0031044609
-
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
-
Procrit Study Group
-
Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group. J Clin Oncol. 1997;15:1218-1234.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1218-1234
-
-
Glaspy, J.1
Bukowski, R.2
Steinberg, D.3
Taylor, C.4
Tchekmedyian, S.5
Vadhan-Raj, S.6
-
27
-
-
0031785826
-
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
-
Procrit Study Group
-
Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16:3412-3425.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3412-3425
-
-
Demetri, G.D.1
Kris, M.2
Wade, J.3
Degos, L.4
Cella, D.5
-
28
-
-
0035366382
-
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing
-
Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol. 2001;19:2875-2882.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2875-2882
-
-
Gabrilove, J.L.1
Cleeland, C.S.2
Livingston, R.B.3
Sarokhan, B.4
Winer, E.5
Einhorn, L.H.6
-
29
-
-
0034982679
-
The erythropoietin receptor
-
Mulcahy L. The erythropoietin receptor. Semin Oncol. 2001;28(2 Suppl 8):19-23.
-
(2001)
Semin Oncol
, vol.28
, Issue.2 SUPPL. 8
, pp. 19-23
-
-
Mulcahy, L.1
-
30
-
-
0027407786
-
The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure
-
Cella D, Tulsky D, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
-
(1993)
J Clin Oncol
, vol.11
, pp. 570-579
-
-
Cella, D.1
Tulsky, D.2
Gray, G.3
-
31
-
-
20644459413
-
Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
-
Zubrod CG, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis. 1960;11:7-33.
-
(1960)
J Chron Dis
, vol.11
, pp. 7-33
-
-
Zubrod, C.G.1
Schneiderman, M.2
Frei, E.3
-
33
-
-
0026877917
-
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
-
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
-
(1992)
Med Care
, vol.30
, pp. 473-483
-
-
Ware, J.E.1
Sherbourne, C.D.2
-
35
-
-
0030922816
-
Bias in meta-analysis detected by a simple graphical test
-
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ. 1997;315:629-634.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Davey Smith, G.2
Schneider, M.3
Minder, C.4
-
36
-
-
0027220373
-
Erythropoietin for anemia in cancer patients
-
Abels R. Erythropoietin for anemia in cancer patients. Eur J Cancer. 1993;29A(Suppl 2):S2-S8.
-
(1993)
Eur J Cancer
, vol.29 A
, Issue.SUPPL. 2
-
-
Abels, R.1
-
37
-
-
0027299160
-
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy
-
Case DC Jr., Bukowski RM, Carey RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst. 1993;85:801-806.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 801-806
-
-
Case Jr., D.C.1
Bukowski, R.M.2
Carey, R.W.3
-
38
-
-
0027239780
-
Erythropoietin treatment of chronic anaemia of cancer
-
Ludwig H, Leitgeb C, Fritz E, et al. Erythropoietin treatment of chronic anaemia of cancer. Eur J Cancer. 1993;29A(Suppl 2):S8-S12.
-
(1993)
Eur J Cancer
, vol.29 A
, Issue.SUPPL. 2
-
-
Ludwig, H.1
Leitgeb, C.2
Fritz, E.3
-
39
-
-
0027753073
-
Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma
-
Ludwig H, Pecherstorfer M, Leitgeb C, Fritz E. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma. Stem Cells. 1993;11:348-355.
-
(1993)
Stem Cells
, vol.11
, pp. 348-355
-
-
Ludwig, H.1
Pecherstorfer, M.2
Leitgeb, C.3
Fritz, E.4
-
40
-
-
0002929285
-
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy
-
Henry DH, Brooks BJ Jr., Case DC Jr., et al. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am. 1995;1:252-260.
-
(1995)
Cancer J Sci Am
, vol.1
, pp. 252-260
-
-
Henry, D.H.1
Brooks Jr., B.J.2
Case Jr., D.C.3
-
41
-
-
0001390321
-
Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer
-
Abels RI, Larholt KM, Krantz KD, Bryant EC. Recombinant human erythropoietin (rHuEPO) for the treatment of the anemia of cancer. Oncologist. 1996;1:140-150.
-
(1996)
Oncologist
, vol.1
, pp. 140-150
-
-
Abels, R.I.1
Larholt, K.M.2
Krantz, K.D.3
Bryant, E.C.4
-
42
-
-
14444276037
-
A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy
-
Pawlicki M, Jassem J, Bosze P, et al. A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy. Anticancer Drugs. 1997;8:949-957.
-
(1997)
Anticancer Drugs
, vol.8
, pp. 949-957
-
-
Pawlicki, M.1
Jassem, J.2
Bosze, P.3
-
43
-
-
0032927104
-
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer
-
Thatcher N, De Campos ES, Bell DR, et al. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer. 1999;80:396-402.
-
(1999)
Br J Cancer
, vol.80
, pp. 396-402
-
-
Thatcher, N.1
De Campos, E.S.2
Bell, D.R.3
-
44
-
-
0035021209
-
Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma
-
Dammacco F, Castoldi G, Rodjer S. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma. Br J Haematol. 2001;113:172-179.
-
(2001)
Br J Haematol
, vol.113
, pp. 172-179
-
-
Dammacco, F.1
Castoldi, G.2
Rodjer, S.3
-
45
-
-
0035503198
-
Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy
-
Canadian Eprex Oncology Study Group
-
Quirt I, Robeson C, Lau CY, et al. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy. Canadian Eprex Oncology Study Group. J Clin Oncol. 2001;19:4126-4134.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4126-4134
-
-
Quirt, I.1
Robeson, C.2
Lau, C.Y.3
-
46
-
-
4744345240
-
Early intervention with epoetin alfa treats anaemia and improves quality of life in ovarian cancer patients undergoing chemotherapy
-
Wilkinson PM, Andersson H, Antonopoulos M, Lahousen M. Early intervention with epoetin alfa treats anaemia and improves quality of life in ovarian cancer patients undergoing chemotherapy [abstract]. Eur J Cancer. 2001;37(6 Suppl):S264.
-
(2001)
Eur J Cancer
, vol.37
, Issue.6 SUPPL.
-
-
Wilkinson, P.M.1
Andersson, H.2
Antonopoulos, M.3
Lahousen, M.4
-
47
-
-
1642516679
-
Once weekly epoetin alfa maintains hemoglobin, improves quality of life and reduces transfusion in breast cancer patients receiving chemotherapy
-
Canadian Eprex Study Group [abstract]
-
Chang J, Couture F. Once weekly epoetin alfa maintains hemoglobin, improves quality of life and reduces transfusion in breast cancer patients receiving chemotherapy. Canadian Eprex Study Group [abstract]. Proc Am Soc Clin Oncol. 2003;22:727.
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 727
-
-
Chang, J.1
Couture, F.2
-
48
-
-
2142858255
-
Comparing the efficacy and safety of fixed vs weight-based dosing of epoetin alfa in anemic cancer patients receiving platinum-based chemotherapy
-
Granetto C, Ricci S, Martoni A, et al. Comparing the efficacy and safety of fixed vs weight-based dosing of epoetin alfa in anemic cancer patients receiving platinum-based chemotherapy. Oncol Rep. 2003;10:1289-1296.
-
(2003)
Oncol Rep
, vol.10
, pp. 1289-1296
-
-
Granetto, C.1
Ricci, S.2
Martoni, A.3
-
49
-
-
0036730276
-
Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence
-
Crawford J. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence. Oncology (Huntingt). 2002;16(9 Suppl 10):41-53.
-
(2002)
Oncology (Huntingt)
, vol.16
, Issue.9 SUPPL. 10
, pp. 41-53
-
-
Crawford, J.1
|